Oculis Holding AG (OCS) Research & Development (2022 - 2026)

Oculis Holding AG's Research & Development history runs 5 years deep, the most recent figure standing at -$17.9 million for Q1 2026.

• In Q1 2026, Research & Development fell 9.18% year-over-year to -$17.9 million; the TTM figure through Mar 2026 stood at -$17.7 billion (down 17.6% YoY), while the FY2025 annual figure was -$68.9 million, down 16.3% from the prior year.
• Research & Development for Q1 2026 stood at -$17.9 million, down from -$16.6 million in the prior quarter.
• The five-year high for Research & Development was -$4.8 million in Q3 2022, with the low at -$17.6 billion in Q3 2025.
• The 5-year median for Research & Development is -$12.9 million (2024), against an average of -$2.1 billion.
• The sharpest annual moves came in 2024 and 2025: Research & Development tumbled 149271.33% in 2024, then grew 1.09% in 2025.
• Oculis Holding AG's Research & Development stood at -$7.2 million in 2022, then retreated by 26.58% to -$9.1 million in 2023, then plunged by 48.35% to -$13.4 million in 2024, then declined by 23.82% to -$16.6 million in 2025, then slipped by 7.89% to -$17.9 million in 2026.
• Business Quant data shows OCS's Research & Development at -$17.9 million in Q1 2026, -$16.6 million in Q4 2025, and -$17.6 billion in Q3 2025.